Celldex Therapeutics Free Cash Flow:
-17.36M for March 31, 2013Celldex Therapeutics Historical Free Cash Flow Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -17.36M |
| Dec. 31, 2012 | -13.44M |
| Sept. 30, 2012 | -11.02M |
| June 30, 2012 | -12.04M |
| March 31, 2012 | -13.60M |
| Dec. 31, 2011 | -9.476M |
| Sept. 30, 2011 | -8.18M |
| June 30, 2011 | -9.445M |
| March 31, 2011 | -9.066M |
| Dec. 31, 2010 | -6.453M |
| Sept. 30, 2010 | -8.275M |
| June 30, 2010 | -10.42M |
| March 31, 2010 | -7.324M |
| Dec. 31, 2009 | -10.93M |
| Sept. 30, 2009 | -5.619M |
| June 30, 2009 | -8.157M |
| March 31, 2009 | -5.69M |
| Dec. 31, 2008 | 1.267M |
| Sept. 30, 2008 | -9.860M |
| June 30, 2008 | 29.89M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More
CLDX Free Cash Flow Benchmarks
| Companies | |
|---|---|
| Ariad Pharmaceuticals | -42.47M |
| Array BioPharma | -30.05M |
| Insmed | -9.094M |
CLDX Free Cash Flow Rankings
| Overall |
50th percentile 3752 of 7593 |
| Sector |
24th percentile 493 of 650 in Healthcare |
| Industry |
34th percentile 155 of 237 in Biotechnology |
CLDX Free Cash Flow Range, Past 5 Years
| Minimum | -17.36M | Mar 2013 |
| Maximum | 29.89M | Jun 2008 |
| Average | -7.259M |
